This article is more than 5 years old. Information may no longer be current.

VIDEO: Review shows anti-VEGFs improve visual, anatomic results in retinal vein occlusion cases

ByNikolas J.S. London, MD

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BALTIMORE ― At the Association for Research in Vision and Ophthalmology meeting here, Nikolas J.S. London, MD, discusses a large, cross-sectional, retrospective analysis of anti-VEGF treatments for both branch retinal vein occlusion and central retinal vein occlusion. The study shows a close similarity to results seen in the SCORE2 trial presented here regarding both visual acuity gains as well as reduction of central retinal thickness on OCT.